The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001971:Bromocriptine / Q000494:pharmacology*; D003480:Cushing Syndrome / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D007003:Hypoglycemia / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects; D010913:Pituitary-Adrenal System / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D001971:Bromocriptine; D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone; D004298:Dopamine; D006854:Hydrocortisone